ALUMIS INC. (ALMS)

↓ Download CSV

CIK 0001847367 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, ALUMIS INC. reported revenue of $24.05M. The company ran a net loss, with a net margin of -1011.7%. It held $411.94M in total assets against $110.64M in total liabilities.

Key ratios (FY2025)

-1886.9%
Operating margin
-1011.7%
Net margin
-80.8%
Return on equity
Metric (FY)2025202420232022
Revenue$24.05M
Operating Income-$453.80M-$300.75M-$158.17M
Net Income-$243.32M-$294.23M-$154.99M
EPS (Diluted)$-2.86$-10.38$-72.08
Total Assets$411.94M$340.99M$89.61M
Total Liabilities$110.64M$80.89M$53.50M
Shareholders' Equity$301.30M$260.10M-$339.26M-$195.24M
Cash & Equivalents$89.67M$169.53M$46.00M
Operating Cash Flow-$369.52M-$255.08M-$129.97M
Capital Expenditures$653.0K$1.73M$4.50M
Shares Outstanding85.03M28.34M2.15M